NCT04138823View on ClinicalTrials.gov

A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours)

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 26, 2019

Primary Completion Date

May 17, 2023

Study Completion Date

May 17, 2023

Conditions
Neoplasm
Interventions
DRUG

BI 891065

film-coated tablets

Trial Locations (1)

104-0045

National Cancer Center Hospital, Tokyo, Chuo-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04138823 - A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours) | Biotech Hunter | Biotech Hunter